Management of thrombosis in the antiphospholipid syndrome

Lupus

Volumn 5, Issue 5, 1996, Pages 463-466

  Khamashta, M A ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Anticardiolipin antibodies; Aspirin; Lupus anticoagulant; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; IMMUNOSUPPRESSIVE AGENT; STEROID; WARFARIN;

ANTIPHOSPHOLIPID SYNDROME; CONFERENCE PAPER; PRIORITY JOURNAL; THROMBOSIS;

EID: 0029830386     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339600500527     Document Type: Conference Paper

References (43)

1. Khamashta MA, Asherson RA. Hughes Syndrome. Antiphospholipid Antibodies move closer to thrombosis in 1994. Br J Rheumatol 1995; 34: 493-494.
2. Hunt BJ, Khamashta MA. Management of the Hughes Syndrome. Clin Exp Rheumatol 1996; 14: 115-117.
3. Lockshin MD. Answers to the antiphospholipid antibody syndrome? N Engl J Med 1995; 332: 1025-1027.
4. Khamashta MA, Hughes GRV. Antiphospholipid Syndrome. A common cause of thrombosis. Br Med J 1993; 307: 883-884.
5. Rivier G, Herranz MT, Khamashta MA, Hughes GRV. Thrombosis and Antiphospholipid Syndrome: a preliminary assessment of three antithrombotic treatments. Lupus 1994; 3: 85-90.
6. Vianna JL et al. Comparison of the primary and secondary antiphospholipid syndrome: a European multicenter study of 114 patients. Am J Med 1994; 36: 3-9.
7. Khamashta MA, Hughes GRV. Antiphospholipid antibodies and antiphospholipid syndrome. Curr Opin Rheumatol 1995; 7: 389-394.
8. Wallace DJ. Does hydroxychloroquine sulfate prevent clot formation in systemic lupus erythematosus. ? Arthritis Rheum 1987, 30: 1435-1436.
9. Wallace DJ, Linker-Israeli M, Metzger A, Stecher VJ. The relevance of antimalarial therapy with regard to thrombosis, hypercholesterolemia and cytokines in SLE. Lupus 1993; 2 (Suppl 1): S13-15.
10. Petri M, et al. Incidence of and predictors of thrombotic events in SLE: protective role of hydroxychloroquine. Arthritis Rheum 1992; 35 (Suppl): S54.
11. McCrae KR. Antiphospholipid antibody-associated thrombosis: a consensus for treatment? Lupus 1996; (in press).
12. Toubi E, Khamashta MA, Panarra A, Hughes GRV. Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus. Am J Med 1995; 99: 397-401.
13. Brey RL. Stroke prevention in patients with antiphospholipid antibodies. Lupus 1994; 3: 299-302.
14. Khamashta MA et al. Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet 1990; 335: 1541-1544.
15. Cervera R. et al. High prevalence of significant heart valve lesions in patients with the primary antiphospholipid syndrome. Lupus 1991; 1: 43-47.
16. Asherson RA, Lubbe WF. Cerebral and valve lesions in systemic lupus erythematosus: association with antiphospholipid antibodies? J Rheumatol 1988; 15: 539-543.
17. Antiphospholipid Antibodies in Stroke Study Group. Clinical and laboratory findings in patients with antiphospholipid antibodies and cerebral ischemia. Stroke 1990; 21: 1268-1273.
18. Khamashta MA, Wallington T. Management of the antiphospholipid syndrome. . Ann Rheum Dis 1991; 50: 959-962.
19. Asherson RA et al. Anticardiolipin antibody, recurrent thrombosis and warfarin withdrawal. Ann Rheum Dis 1985; 44: 823-825.
20. Khamashta MA et al. The management of thrombosis in the antiphospholipid antibody synrome. N Engl J Med 1995; 332: 993-997.
21. Rosove MH, Brewer PMC. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 1992; 117: 303-308.
22. Derksen RHWM, De Groot PHG, Kater L, Nieuwenhuis HK. Patients with antiphospholipid antibodies and venous thrombosis should receive long-term anticoagulant treatment. Ann Rheum Dis 1993; 52: 689-692.
23. Hirsh J, Hoak J. Management of deep vein thrombosis and pulmonary embolism. Circulation 1996; 93: 2212-2245.
24. De stefano V, Finazzi G, Mannucci M. Inherited thrombophilia: pathogenesis, clinical syndromes, and management. Blood 1996; 87: 3531-3544.
25. Khamashta MA, Taub NA, Hunt BJ. Thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995; 333: 665-667.
26. Ginsberg JS et al. Antiphospholipid antibodies and venous thromboembolism. Blood 1995, 86: 3685-3691.
27. Lima F et al. A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumatol 1996; 14: 131-136.
28. Khamashta MA, Hughes GRV. Pregnancy in systemic lupus erythematosus. Curr Opin Rheumatol 1996; (in press).
29. Italian Registry of Antiphospholipid Antibodies: Thrombosis and thrombocytopenia in antiphospholipid syndrome (idiopathic and secondary to SLE): first report from the Italian registry. Haematologica 1993; 78: 313-318.
30. Alarcon-Segovia D, Sanchez-Guerrero J. Correction of thrombocytopenia with small dose aspirin in the primary antiphospholipid syndrome. J Rheumatol 1989; 16: 482-488.
31. Durand JM et al. Correction of thrombocytopenia with dapsone in the primary antiphospholipid syndrome. J Rheumatol 1993; 20: 1777-1778.
32. Kavanaugh HA. Danazol therapy in thrombocytopenia associated with the antiphospholipid antibody syndrome. Ann Intern Med 1994; 121: 767-768.
33. Martin-Suarez I et al. Correction of severe thrombocytopenia with chloroquine in the primary antiphospholipid syndrome. Lupus 1996; 5: 81-83.
34. Yamazaki M, Asakura H, Matsuda T. Resolution of thrombocytopenia in a patient with lupus anticoagulant who received warfarin therapy. Acta Haematol 1994; 92: 52-53.
35. Pallares JA, Caba F. Implicaciones anestesicas en el sindrome an tifosfolipido. Dos Casos Clinicos. Res Esp Anestesiol Reanim 1995; 42: 182-185.
36. Singleton JD, Conyers L. Warfarin and azathioprine: an important drug interaction. Am J Med 1992; 92: 217.
37. Rivier G, Khamashta MA, Hughes GRV. Warfarin and azathoprine: a drug interaction does exist. Am J Med 1993; 95: 342.
38. Asherson RA, Baguley E, Pal C, Hughes GRV. Antiphospholipid syndrome: five year follow-up. Ann Rheum Dis 1991; 50: 805-810.
39. Asherson RA. The catastrophic antiphospholipid syndrome. J Rheumatol 1992; 19: 508-512.
40. Gertner E, Lie JT. Systemic therapy with fibrinolytic agents and heparin for recalcitrant non-healing cutaneous ulcer in the antiphospholipid syndrome. J Rheumatol 1994; 21: 2159-2161.
41. Camps MT et al. Fibrinolytic treatment in primary antiphospholipid syndrome. Lupus 1996; (in press).
42. Zahavi J et al. Ischaemic necrotic toes associated with anti-phospholipid syndrome and treated with iloprost. Lancet 1993; 342: 862.
43. Saadoval J et al. Primary Antiphospholipid Syndrome presenting as chronic thromboembolic pulmonary hypertension. Treatment with thromboendarterectomy. J Rheumatol 1996; 23: 772-775.